Regulation of the endogenous NO pathway by prolonged inhaled NO in rats

Journal of Applied Physiology

Volumn 85, Issue 3, 1998, Pages 1070-1078

  Frank, Deborah U ^a   Horstman, Damian J ^a   Morris, Geoffrey N ^a   Johns, Roger A ^a   Rich, George F ^a,b  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Chronic hypoxia; Cyclic 3',5' guanosine monophosphate; Guanylate cyclase; Nitric oxide; Nitric oxide synthase; Pulmonary hypertension; Pulmonary vasodilation

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; CYCLIC GMP; GUANYLATE CYCLASE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; THROMBOXANE A2 RECEPTOR STIMULATING AGENT; VASODILATOR AGENT;

ANIMAL EXPERIMENT; ARTICLE; ENZYME ACTIVITY; HYPOXIA; INHALATIONAL DRUG ADMINISTRATION; ISOLATED LUNG; LUNG BLOOD VESSEL; MALE; NONHUMAN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RAT; VASODILATATION;

EID: 0031709383     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/jappl.1998.85.3.1070     Document Type: Article

References (38)

1. Abraham, A. S., J. M. Kay, R. B. Cole, and A. C. Pincock. Haemodynamic and pathological study of the effect of chronic hypoxia and subsequent recovery of the heart and pulmonary vasculature of the rat. Cardiovasc. Res. 5: 95-102, 1971.
2. Assreuy, J., F. Q. Cunha, F. Y. Liew, and S. Moncada. Feedback inhibition of nitric oxide synthase activity by nitric oxide Br. J. Pharmacol. 180: 833-837, 1993.
3. Bennett, B. M., H. Schröder, L. D. Hayward, S. A. Waldman, and F. Murad. Effect of an in vitro organic nitrate tolerance on relaxation, cyclic GMP accumulation, and guanylate cyclase activation by glyceryl trinitrate and the enantiomers of isoidide dinitrate. Circ. Res. 63: 693-701, 1988.
4. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254, 1976.
5. Buga, G. M., J. M. Griscavage, N. E. Rogers, and L. J. Ignarro. Negative feedback regulation of endothelial cell function by nitric oxide. Circ. Res. 73: 808-812, 1993.
6. Carville, C., S. Adnot, S. Eddahibi, E. Teiger, D. Rideau, and B. Raffestin. Induction of nitric oxide synthase activity in pulmonary arteries from normoxic and chronically hypoxic rats. Eur. Respir. J. 10: 437-445, 1997.
7. Combes, X., M. Mazmanian, H. Gourlain, and P. Hervé. Effect of 48 hours of nitric oxide inhalation on pulmonary vasoreactivity in rats. Am. J. Respir. Crit. Care Med. 156: 473-477, 1997.
8. DeGaravilla, L., M. L. Volberg, P. F. Pratt, P. J. Silver, and R. A. Buchholz. Lack of cross-tolerance between nitroglycerin and endothelium-derived relaxing factor-mediated vasoactive agents in spontaneously hypertensive rats. Eur. J. Pharmacol. 234: 77-82, 1993.
9. Griscavage, J. M., J. M Fukuto, Y. Komori, and L. J. Ignarro. Nitric oxide inhibits neuronal nitric oxide synthase by interacting with the heme prosthetic group. J. Biol. Chem. 269: 21644-21649, 1994.
10. Kiff, R. J., D. W. Moss, and S. Moncada. Effect of nitric oxide gas on the generation of nitric oxide by isolated blood vessels: implications for inhalational therapy. Br. J. Pharmacol. 113: 496-498, 1994.
11. Kurrek, M. M., L. Castillo, K. D. Bloch, S. R. Tannenbaum, and W. M. Zapol. Inhaled nitric oxide does not alter endotoxin-induced nitric oxide synthase activity during rat lung perfusion. J. Appl. Physiol. 79: 1088-1092, 1995.
12. Kurrek, M. M., W. M. Zapol, A. Holzmann, G. Flippov, M. Winkler, and K. D. Bloch. In vivo lipopolysaccharide pretreatment inhibits cGMP release from the isolated-perfused rat lung. Am. J. Physiol. 269 (Lung Cell. Mol. Physiol. 13): L618-L624, 1995.
13. Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4 (Abstract). Nature 227: 680-685, 1970.
14. Lavoie, A., J. B. Hall, D. M. Olson, M. E. Wylam. Life-threatening effects of discontinuing inhaled nitric oxide in severe respiratory failure. Am. J. Respir. Crit. Care Med. 153: 1985-1987, 1996.
15. LeCras, T. D., D. U. Frank, G. F. Rich, and R. A. Johns. Increased soluble guanylate cyclase mRNAand activity in chronically hypoxic rat lung (Abstract). J. Vasc. Res. 33, Suppl 1: 57, 1996.
16. LeCras, T. D., C. Xue, A. Rengasamy, and R. A. Johns. Chronic hypoxia upregulated endothelial and inducible NO synthase gene and protein expression in rat lung. Am. J. Physiol. 270 (Lung Cell. Mol. Physiol. 14): L164-L170, 1996.
17. Mallikharjuna, V. S. N., R. Karamsetty, K. A. Kane, and R. M. Wadsworth. The effects of chronic hypoxia on the pharmacological responsiveness of the pulmonary artery. Pharmacol. Ther. 68: 233-246, 1995.
18. Maramatsu, M., R. C. Tyler, J. Gutkowska, J. R. Klinger, N. S. Hill, D. M. Rodman, and I. F. McMurtry. Atrial natriuretic peptide accounts for increased cGMP in hypoxia-induced hypertensive rat lungs. Am. J. Physiol. 272 (Lung Cell. Mol. Physiol. 16): L1126-L1132, 1997.
19. McDonald, L. J., and F. Murad. Nitric oxide and cyclic GMP signaling. Proc. Soc. Exp. Biol. Med. 211: 1-6, 1996.
20. Millatt, L. J., L. V. Ravichandran, and R. A. Johns. Regulation of type III nitric oxide synthase gene expression by nitric oxide. FASEB J. 10: A436, 1996.
21. Moncada, S., D. D. Rees, R. Schulz, and R. M. J. Palmer. Development and mechanism of a specific supersensitivity to nitrovasodilators after inhibition of vascular nitric oxide synthesis in vivo. Proc. Natl. Acad. Sci. USA 88: 2166-2170, 1991.
22. Moncada, S., and A. Higgs. The L-arginine-nitric oxide pathway. N. Engl. J. Med. 329: 2002-2012, 1993.
23. Morrell, N. W., E. N. Atochina, K. G. Morris, S. M. Danilov, and K. R. Stenmark. Angiotensin converting enzyme expression is increased in small pulmonary arteries of rats with hypoxia-induced pulmonary hypertension. J. Clin. Invest. 96: 1823-1833, 1995.
24. Murad, F. Regulation of cytosolic guanylyl cyclase by nitric oxide: the NO-cyclic GMP signal transduction system. Adv. Pharmacol. 26: 19-33, 1994.
25. Oka, M., M. Ohnishi, H. Takahashi, S. Soma, K. Hasunuma, K. Sato, and S. Kira. Altered vasoreactivity in lungs isolated from rats exposed to nitric oxide gas. Am. J. Physiol. 271 (Lung Cell. Mol. Physiol. 15): L419-L424, 1996.
26. Papapetropoulos, A., C. Y. Go, F. Murad, and J. D. Catravas. Mechanisms of tolerance to sodium nitroprusside in rat cultured aortic smooth muscle cells. Br. J. Pharmacol. 117: 147-155, 1996.
27. Patel, J. M., J. Zhang, and E. R. Block. Nitric oxide-induced inhibition of lung endothelial cell nitric oxide synthase via interaction with allosteric thiols: role of thioredoxin in regulation of catalytic activity. Am. J. Respir. Cell Mol. Biol. 15: 410-419, 1996.
28. Ravichandran, L. V., R. A. Johns, and A. Rengasamy. Direct and reversible inhibition of endothelial nitric oxide synthase by nitric oxide. Am. J. Physiol. 268 (Heart Circ. Physiol. 37): H2216-H2223, 1995.
29. Rengasamy, A., and R. A. Johns. Regulation of nitric oxide synthase by nitric oxide. Mol. Pharmacol. 44: 124-128, 1993.
30. Rengasamy, A., and R. A. Johns. Characterization of endothelium-derived relaxing factor/nitric oxide synthase from bovine cerebellum and mechanism of modulation by high and low oxygen tensions. J. Pharmacol. Exp. Ther. 259: 301-316, 1991.
31. Roos, C. M., D. U. Frank, C. Xue, B. A. Johns, and G. F. Rich. Chronic inhaled nitric oxide: effects on pulmonary vascular endothelial function and pathology in rats. J. Appl. Physiol. 80: 252-260, 1996.
32. Rossaint, R., H. Gerlach, H. Schmidt-Ruhnke, D. Pappert, K. Lewandowski, W. Steudel, and K. Falke. Efficacy of inhaled nitric oxide in patients with severe ARDS. Chest 107: 1107-1115, 1995.
33. Shaul, P. W., A. J. North, T. S. Brannon, K. Ujiie, L. B. Wells, P. A. Nisen, C. J. Lowenstein, S. H. Snyder, and R. A. Star. Prolonged in vivo hypoxia enhanced nitric oxide synthase type I and type III gene expression in adult rat lung. Am. J. Respir. Cell Mol. Biol. 13: 167-174, 1995.
34. Stalcup, S. A., J. S. Lipset, and R. B. Mellins. Modulation of converting enzyme activity by hypoxia and its physiological effects. Ciba Found. Symp. 78: 293-311, 1980.
35. Stamler, J. S. Redox signaling: nitrosylation and related target interactions of nitric oxide. Cell 78: 931-936, 1994.
36. Winter, R. J. D., L. Meleagros, S. Pervez, H. Jamal, T. Krausz, J. M. Polak, and S. R. Bloom. Atrial natriuretic peptide levels in plasma and in cardiac tissues after chronic hypoxia in rats. Clin. Sci. (Colch.) 76: 95-101, 1989.
37. Xue, C., A. Rengasamy, T. D. LeCras, P. A. Koberna, G. C. Dailey, and R. A. Johns. Distribution of NOS in normoxic vs. hypoxic rat lung: upregulation of NOS by chronic hypoxia. Am. J. Physiol. (Lung Cell. Mol. Physiol. 15) 267: L667-678, 1994.
38. Zuo, Z., and R. A. Johns. Halothane, enflurane, and isoflurane do not affect the basal or agonist-stimulated activity of partially isolated soluble and particulate guanylyl cyclases of rat brain. Anesthesiology 83: 395-404, 1995.